tiprankstipranks
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study
Company AnnouncementsAbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study
7h ago
ABBV
AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch
PremiumCompany Announcements
AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch
7h ago
ABBV
AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now
PremiumCompany Announcements
AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now
7h ago
ABBV
AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study
PremiumCompany Announcements
AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study
1d ago
ABBV
AbbVie price target raised to $303 from $298 at Piper Sandler
PremiumThe Fly
AbbVie price target raised to $303 from $298 at Piper Sandler
2d ago
ABBV
AbbVie Raises $9 Billion Debt to Fund Acquisition
PremiumCompany AnnouncementsAbbVie Raises $9 Billion Debt to Fund Acquisition
3d ago
8K
ABBV
3 Dividend ETFs Crushing the S&P 500 in 2026
Premium
Market News
3 Dividend ETFs Crushing the S&P 500 in 2026
4d ago
VZ
CVX
AbbVie price target raised to $300 from $295 at Wells Fargo
Premium
The Fly
AbbVie price target raised to $300 from $295 at Wells Fargo
5d ago
ABBV
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
PremiumThe Fly
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
5d ago
ABBV
Apogee Therapeutics price target raised to $135 from $81 at Truist
PremiumThe Fly
Apogee Therapeutics price target raised to $135 from $81 at Truist
5d ago
ABBV
APGE
AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors
PremiumCompany Announcements
AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors
7d ago
ABBV
AbbVie Wraps Real‑World China Study on Upadacitinib in Atopic Dermatitis: What Investors Should Watch
PremiumCompany Announcements
AbbVie Wraps Real‑World China Study on Upadacitinib in Atopic Dermatitis: What Investors Should Watch
7d ago
ABBV
Rinvoq vs. Humira: AbbVie’s SELECT‑SWITCH Data Could Reshape Its RA Portfolio
PremiumCompany AnnouncementsRinvoq vs. Humira: AbbVie’s SELECT‑SWITCH Data Could Reshape Its RA Portfolio
7d ago
ABBV
AbbVie’s BOTOX Jawline Trial Wraps Up: What the Masseter Study Means for ABBV Investors
Premium
Company Announcements
AbbVie’s BOTOX Jawline Trial Wraps Up: What the Masseter Study Means for ABBV Investors
9d ago
ABBV
AbbVie’s Venetoclax Combo in High-Risk MDS: What a Fresh Trial Update Signals for Investors
Premium
Company Announcements
AbbVie’s Venetoclax Combo in High-Risk MDS: What a Fresh Trial Update Signals for Investors
9d ago
ABBV
AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial
PremiumCompany Announcements
AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial
10d ago
ABBV
AbbVie price target raised to $260 from $246 at Evercore ISI
PremiumThe Fly
AbbVie price target raised to $260 from $246 at Evercore ISI
11d ago
ABBV
AbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial
PremiumCompany Announcements
AbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial
14d ago
ABBV
AbbVie prices $9.9B senior notes to fund acquisition
PremiumCompany Announcements
AbbVie prices $9.9B senior notes to fund acquisition
16d ago
8K
ABBV
AbbVie upgraded to Buy from Hold at Erste Group
PremiumThe FlyAbbVie upgraded to Buy from Hold at Erste Group
16d ago
ABBV
AbbVie Stock Forecast: Trending Strong Buy Among Analysts
Premium
Analysts
AbbVie Stock Forecast: Trending Strong Buy Among Analysts
17d ago
ABBV
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
Premium
The Fly
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
17d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >